For a novel compound like 5-amino-1MQ, microdosing could be an appropriate strategy, as it may provide insights into the compound's metabolism, biological activity, and safety profile
Because this is a small-molecule salt rather than a peptide, the usual peptide precautions about mechanical shear and methionine or tryptophan oxidation do not apply
AOD-9604 Research Applications Lipolysis and lipid-metabolism assays in adipocyte cell models
For instance, a protocol focused on enhancing overall cellular health and mitochondrial function might start with 5 Amino 1mq to recalibrate NAD+ levels, then potentially introduce AOD-9604 for targeted adipose tissue reduction
The peptide was investigated by Australian pharmaceutical company Lateral Pharma as a potential management of migraines and neuropathic pain, but the results were similar to placebo [10, 11]